Iria González

Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer

Sabrina Arena, Beatríz Bellosillo, Giulia Siravegna et al. · Clinical Cancer Research · 2015 · 275 citations · Full text

Medicine, Oncology, Pharmacology +13

Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors

José María Serrano Sanz, Iria González, Silvia del Castillo et al. · The Oncologist · 2015 · 80 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer

Andreas Schneeweiß, Tjoung‐Won Park‐Simon, Joan Albanell et al. · Investigational New Drugs · 2018 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients

Israel Cañadas, Álvaro Taus, Iria González et al. · Oncotarget · 2014 · 40 citations · Full text

Medicine, Oncology, Pathology +13

Assessment of ALK Status by FISH on 1000 Spanish Non-Small Cell Lung Cancer Patients

Joana Vidal, Sergi Clavé, Silvia de Muga et al. · Journal of Thoracic Oncology · 2014 · 29 citations

Medicine, Cancer Biology, Oncology +8